Skip to content

Study on the Safety and Efficacy of Perioperative Dexamethasone Administration in Hip and Knee Revision Arthroplasty

Study on the Safety and Efficacy of Perioperative Dexamethasone Administration in Hip and Knee Revision Arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091108
Enrollment
Unknown
Registered
2024-10-21
Start date
2024-10-22
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip and knee joint disease

Interventions

Group of patients underwent hip or knee revision surgery:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who underwent hip or knee revision surgery in our Joint Unit between January 2008 and December 2023 were retrospectively included.

Exclusion criteria

Exclusion criteria: Exclusion of patients undergoing revision surgery for periprosthetic fracture or dislocation; patients with incomplete relevant data

Design outcomes

Primary

MeasureTime frame
VAS scores;CRP;IL-6;Usage of analgesic drugs;Incidence of postoperative nausea and vomiting ;Usage of antiemetic drugs;Incidence of postoperative complications (including wound complications, periprosthetic infections, and gastrointestinal bleeding);Total length of hospital stay after surgery;

Countries

China

Contacts

Public ContactZongke Zhou

West China Hospital, Sichuan University

zongke@126.com+86 132 0819 3509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026